pharma · Ventilator-Associated Pneumonia · Carcinoma, Squamous Cell
Janssen Research &
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Janssen Research & congress and investor events — 8 upcoming or recent appearances from our events calendar.
Raritan, USA HQ
2001 Founded
95 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Raritan, USA
- Founded
- 2001
- Employees
- 95
- Programs
- 7
- Drugs
- 4
- Patents
- 0
Events
Janssen Research & congress and investor events — 8 upcoming or recent appearances from our events calendar.
Janssen Research & congress and investor events — 8 upcoming or recent appearances from our events calendar.
Congress participation 3
- CongressASCO 2026
- CongressASCO
- CongressBio-IT World Conference
Presentations & abstracts 5
- PresentationUpdated results from the open-label Phase I/Ib CHRYSALIS-2 study (NCT04077463) of amivantamab and lazertinib in non-small cell lung cancer
- PresentationLazertinib as first-line therapy in EGFR-mutant NSCLC: updated overall survival from LASER301
- PresentationData for amivantamab in lung cancer
- PresentationUpdated results from the open-label Phase I/Ib CHRYSALIS-2 study (NCT04077463)
- PresentationData for lazertinib in lung cancer